Linda, pursued by ash-flow tuff Voodoos!
I often
forget that cancer research is, to a large extent, a business, and I somewhat
irrationally recoil from articles that examine it as a money-making
proposition. I write this because I
initially learned of the scientific development described below through web sites giving stock-market
tips! The company behind the tips is
Celsion Corporation, headquartered in Lawrenceville, New Jersey, employing 29
persons, and tendering a stock valued, at this moment, $2.09 per share. As far as I can see, Celsion has never even
come close to making a profit, but I hope that will change with the following
innovation:
Apparently
Celsion has succeeded in devising a means of delivering an important
cancer-destroying drug directly to the tumor, using nanoparticles, rather than pumping
the stuff into the blood-stream and hoping for the best. It appears that Celsion has received “fast
track” status from the FDA for its new baby.
Let us hope.
So maybe I should
buy a few shares?
No comments:
Post a Comment